A clinical evaluation of levomepromazine in anaesthesia.

A clinical evaluation of levomepromazine in anaesthesia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A clinical evaluation of levomepromazine in anaesthesia. Abstract Text:

A ROMAGNOLI,M COHEN,M J DIAMOND,

A clinical evaluation of levomepromazine in anaesthesia. Publishing Authors By Initials

A ROMAGNOLI,M COHEN,MJ DIAMOND,

For similar anesthesia and analgesia: anesthesia research abstracts see: anesthesia and analgesia: anesthesia research

PUBMED ID PMID:

MEDLINE DATE:

A clinical evaluation of levomepromazine in anaesthesia. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Canadian Anaesthetists' Society journal

VOLUME: 6

Page Numbers: 263-6

Journal Abbreviation:

ISSN: 0008-2856

DAY: 24

MONTH: Jul

YEAR: 1959

A clinical evaluation of levomepromazine in anaesthesia. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 371163

A clinical evaluation of levomepromazine in anaesthesia. Keywords Mesh Terms:

KEYWORDS: Anesthesia

MESH TERMS:

Chemical & Substance for Abstract: A clinical evaluation of levomepromazine in anaesthesia. Information

Substance Name: phenothiazine

Registry Number: 92-84-2

Grant and Affiliation Information for A clinical evaluation of levomepromazine in anaesthesia.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Can Anaesth Soc J

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A clinical evaluation of levomepromazine in anaesthesia Related Publications

• A word to the wise: Tips for the first-time traveler.
• Ambient manganese exposure is negatively associated with human sperm motility and concentration.
• Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.
• Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells.
• Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.
• Biotinylated photocleavable polyethylenimine: capture and triggered release of nucleic acids from solid supports.
• CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.
• CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitis.
• Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis.
• Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms.
• Consequences of variations in genes that affect dopamine in prefrontal cortex.
• Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model.
• Enhanced discrimination of single nucleotide polymorphism in genotyping by phosphorothioate proofreading allele-specific amplification.
• Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients.
• Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters.
• In vivo beta-defensin gene expression in rat gingival epithelium in response to Actinobacillus actinomycetemcomitans infection.
• Interrelated and interdependent.
• Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease.
• Matrix protein microarrays for spatially and compositionally controlled microspot thrombosis under laminar flow.
• Methods for mapping protease specificity.
• Microinfusion of pituitary adenylate cyclase-activating polypeptide into the central nucleus of amygdala of the rat produces a shift from an active to passive mode of coping in the shock-probe fear/defensive burying test.
• Novel integrated paired emitter-detector diode (PEDD) as a miniaturized photometric detector in HPLC.
• Selenium and GPx-1 overexpression protect mammalian cells against UV-induced DNA damage.
• Synthesis and structure-activity relationships of a series of increasingly hydrophobic cationic steroid lipofection reagents.
• Systemic lupus erythematosus and Sjögren's syndrome.
• The molecular basis of antibody-mediated neutralization of West Nile virus.
• The relationship of antipsychotic medication class and adherence with treatment outcomes and costs for Florida Medicaid beneficiaries with schizophrenia.
• Thresholds in songbird occurrence in relation to landscape structure.
• Time and recruitment costs as currencies in manipulation studies on the costs of reproduction.
• West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H.